Carditis after COVID-19 vaccination with a messenger RNA vaccine and an inactivated virus vaccine: a case–control study
Background: Case reports of carditis after BNT162b2 vaccination are accruing worldwide.
Objective: To examine the association of BNT162b2 and CoronaVac (Sinovac) vaccination …
Objective: To examine the association of BNT162b2 and CoronaVac (Sinovac) vaccination …
Myocarditis after Covid-19 vaccination in a large health care organization
Background Reports have suggested an association between the development of
myocarditis and the receipt of messenger RNA (mRNA) vaccines against coronavirus …
myocarditis and the receipt of messenger RNA (mRNA) vaccines against coronavirus …
[HTML][HTML] Myocarditis after BNT162b2 mRNA vaccine against Covid-19 in Israel
D Mevorach, E Anis, N Cedar… - … England Journal of …, 2021 - Mass Medical Soc
Abstract Background Approximately 5.1 million Israelis had been fully immunized against
coronavirus disease 2019 (Covid-19) after receiving two doses of the BNT162b2 messenger …
coronavirus disease 2019 (Covid-19) after receiving two doses of the BNT162b2 messenger …
[HTML][HTML] Risk of myocarditis and pericarditis following BNT162b2 and mRNA-1273 COVID-19 vaccination
Background Evidence indicates that mRNA COVID-19 vaccination is associated with risk of
myocarditis and possibly pericarditis, especially in young males. It is not clear if risk differs …
myocarditis and possibly pericarditis, especially in young males. It is not clear if risk differs …
[HTML][HTML] Myocarditis and/or pericarditis risk after mRNA COVID-19 vaccination: a Canadian head to head comparison of BNT162b2 and mRNA-1273 vaccines
Background Canadian and international data suggest the risk of myocarditis and/or
pericarditis is elevated during the week after mRNA COVID-19 vaccination, particularly in …
pericarditis is elevated during the week after mRNA COVID-19 vaccination, particularly in …
Association of myocarditis with BNT162b2 messenger RNA COVID-19 vaccine in a case series of children
A Dionne, F Sperotto, S Chamberlain, AL Baker… - JAMA …, 2021 - jamanetwork.com
Importance The BNT162b2 (Pfizer-BioNTech) messenger RNA COVID-19 vaccine was
authorized on May 10, 2021, for emergency use in children aged 12 years and older. Initial …
authorized on May 10, 2021, for emergency use in children aged 12 years and older. Initial …
[HTML][HTML] Myocarditis and pericarditis following COVID-19 vaccination: inequalities in age and vaccine types
An increasing number of myocarditis/pericarditis incidences has been reported after
coronavirus disease-19 (COVID-19) vaccination in adolescents and young adults. This study …
coronavirus disease-19 (COVID-19) vaccination in adolescents and young adults. This study …
[HTML][HTML] Risk of myocarditis and pericarditis after the COVID-19 mRNA vaccination in the USA: a cohort study in claims databases
HL Wong, M Hu, CK Zhou, PC Lloyd, KL Amend… - The Lancet, 2022 - thelancet.com
Background Several passive surveillance systems reported increased risks of myocarditis or
pericarditis, or both, after COVID-19 mRNA vaccination, especially in young men. We used …
pericarditis, or both, after COVID-19 mRNA vaccination, especially in young men. We used …
Myocarditis or pericarditis following mRNA COVID-19 vaccination
ES Weintraub, ME Oster, NP Klein - JAMA network open, 2022 - jamanetwork.com
Buchan and colleagues1 describe findings from a population-based cohort study in Ontario,
Canada, that used data from a passive vaccine-safety surveillance system to evaluate …
Canada, that used data from a passive vaccine-safety surveillance system to evaluate …
Myocarditis cases reported after mRNA-based COVID-19 vaccination in the US from December 2020 to August 2021
Importance Vaccination against COVID-19 provides clear public health benefits, but
vaccination also carries potential risks. The risks and outcomes of myocarditis after COVID …
vaccination also carries potential risks. The risks and outcomes of myocarditis after COVID …